Prospects for gene therapy now and in the future

Journal of Inherited Metabolic Disease
R J Akhurst

Abstract

Advances in gene technology and cell biology have supplied the means to undertake human gene therapy in the near future. Techniques have been developed for the efficient introduction of gene sequences into the pluripotential stem cells of the haematopoietic system and our increased understanding of gene-regulatory mechanisms should allow therapeutic gene expression levels to be obtained. Gene therapy should, at present, be termed gene supplementation since it will involve the addition of corrective genes to the host cell genome. It may only be used to treat recessively inherited disorders. Prospects for the future include the use of homologous recombination to correct or replace defective genes, allowing the treatment of dominantly inherited diseases.

References

Apr 7, 1988·Nature·R HiguchiH A Erlich
Mar 20, 1986·Nature·M Robertson
Mar 20, 1986·Nature·L Walters
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S F YuE Gilboa
Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D A WilliamsR C Mulligan
Aug 10, 1984·Science·A D MillerI M Verma

❮ Previous
Next ❯

Citations

Jan 1, 1990·Human Gene Therapy
May 11, 2007·Journal of Paediatrics and Child Health·Donald S Anson, Janice M Fletcher
Feb 16, 2006·Journal of Applied Microbiology·F C HerreraM-L García-López

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2022 Meta ULC. All rights reserved